Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bialystok
Clinical trial register · Poland

Clinical Trials in Bialystok, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 21 Lublin 18 Krakow 16 Bialystok 16 Wroclaw 13
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw21 Lublin18 Krakow16 Bialystok16 Wroclaw13
All 55 locations
Target enrolment
to

Trials with a site in Bialystok

16 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Lublin, Gorzów Wielkopolski, Grodzisk Mazowiecki, Ostrów Mazowiecka, Warsaw, Bialystok, Częstochowa, Bielsko-Biala
2026-10-26
Recruiting
Novo Nordisk A/S
Phase 3
450
Bialystok, Bydgoszcz, Bygdoszcz, Lodz, Poznan, Staszów, Warsaw
2026-08-12
Recruiting
Novo Nordisk A/S
Phase 2
300
Lublin, Bialystok, Kielce, Oświęcim
2026-06-22
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bialystok, Bydgoszcz, Dębica, Katowice, Krakow, Poznan, Rzeszów, Warsaw
2026-05-21
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Lublin, Grudziądz, Bialystok, Elblag, Gorzów Wielkopolski, Kalwaria Zebrzydowska, Krakow, Legnica
2026-05-20
Recruiting
Novo Nordisk A/S
Phase 3
400
Bialystok, Bydgoszcz, Krakow, Warsaw
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 2
270
Bialystok, Lublin, Oświęcim, Warsaw, Zabrze
2026-04-17
Recruiting
Novo Nordisk A/S
Phase 3
400
Bialystok, Bydgoszcz, Krakow, Warsaw
2026-04-13
Active, closed
Novo Nordisk A/S
Phase 3
300
Bialystok, Katowice, Lublin, Warsaw
2025-11-05
Recruiting
Novo Nordisk A/S
Phase 1
30
Bialystok, Gdansk, Katowice, Lublin, Poznan, Warsaw
2025-10-23
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Biała Podlaska, Bielsko-Biala, Krakow, Przemyśl, Warsaw
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Szczecin, Bielsko-Biala, Krakow, Lodz, Przemyśl
2025-06-27
Recruiting
Novo Nordisk A/S
Phase 2
465
Włocławek, Lublin, Rzeszów, Bialystok, Gmina Świecie, Katowice, Lodz, Olsztyn
2024-12-02
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bydgoszcz, Krakow, Legnica, Lublin, Warsaw, Bialystok, Gdansk, Katowice
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Bialystok, Bydgoszcz, Chorzów, Gdansk, Katowice, Krakow, Lodz, Poznan
2019-05-08
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/bialystok

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Bialystok that also match the filters currently applied.

How many clinical trials are recruiting in Bialystok?

11 of the 16 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bialystok), 16 studies
PhaseStudiesRecruitingShare
Phase 310562.5%
Phase 25531.3%
Phase 1116.3%

Most active sponsors

Lead sponsors with the most studies (Bialystok)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S1611
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.